Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 3/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 5/6 |
Shanghai Pharmaceuticals Holding Co., Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥1.49 |
52 Week High | CN¥2.08 |
52 Week Low | CN¥1.21 |
Beta | 0.25 |
1 Month Change | 1.02% |
3 Month Change | 17.86% |
1 Year Change | n/a |
3 Year Change | -19.73% |
5 Year Change | -33.11% |
Change since IPO | -27.56% |
Recent News & Updates
Recent updates
Shareholder Returns
SHPM.F | US Healthcare | US Market | |
---|---|---|---|
7D | 0% | 0.6% | 0.4% |
1Y | n/a | 9.5% | 28.8% |
Return vs Industry: Insufficient data to determine how SHPM.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how SHPM.F performed against the US Market.
Price Volatility
SHPM.F volatility | |
---|---|
SHPM.F Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 7.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SHPM.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SHPM.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 47,811 | Bo Shen | https://www.sphchina.com |
Shanghai Pharmaceuticals Holding Co., Ltd. researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including anti-tumor, heart and cerebral vessels, psychoneural, anti-infection, auto-immunity, digestive tract and metabolism, and respiratory system.
Shanghai Pharmaceuticals Holding Co., Ltd Fundamentals Summary
SHPM.F fundamental statistics | |
---|---|
Market cap | US$7.92b |
Earnings (TTM) | US$636.50m |
Revenue (TTM) | US$35.27b |
13.7x
P/E Ratio0.2x
P/S RatioIs SHPM.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
SHPM.F income statement (TTM) | |
---|---|
Revenue | CN¥254.88b |
Cost of Revenue | CN¥223.22b |
Gross Profit | CN¥31.66b |
Other Expenses | CN¥27.06b |
Earnings | CN¥4.60b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Mar 28, 2024
Earnings per share (EPS) | 1.24 |
Gross Margin | 12.42% |
Net Profit Margin | 1.80% |
Debt/Equity Ratio | 64.5% |
How did SHPM.F perform over the long term?
See historical performance and comparison